Pancreatic Cancer Research

ResearcherKarlsruhe Institute of TechnologyActive in the last 2 years

Véronique Orian‐Rousseau

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2939-9257; OpenAlex author ID A5001313744. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Loss of CD44 re-educates pancreatic cancer-associated fibroblasts modulating their fibrotic and immunosuppressive functions. Last author DOI 10.1038/s41419-026-09155-5↗
  2. Reprogramming Immunosuppressive Bone Marrow–Derived Cells via CD44 Targeting Impacts Pancreatic Cancer Metastasis Last author DOI 10.1101/2025.08.13.670111↗
  3. Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling. Last author DOI 10.1053/j.gastro.2015.10.020↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sven Máté Treffert · 2 shared papers, 2025–2026 · strength 0.51
  2. Lisa-Marie Mehner · 2 shared papers, 2025–2026 · strength 0.51
  3. Matthias M. Gaida · 1 shared paper, 2025 · strength 0.26
  4. Alexandra Matzke‐Ogi · 1 shared paper, 2016 · strength 0.05
  5. Frauke Alves · 1 shared paper, 2016 · strength 0.05
  6. Jorg H. Kleeff · 1 shared paper, 2016 · strength 0.05
  7. Jennifer P. Morton · 1 shared paper, 2016 · strength 0.05
  8. Owen James Sansom · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.